Mersana Therapeutics Inc Cash Flow Quality Index
Latest as of March 2019:
-1.13x
Mersana Therapeutics Inc cash flow quality index. Mersana Therapeutics Inc (MRSN) has a Cash Flow Quality Index of -1.13x as of March 2019. Operating cash flow of $-24.69 Million is below net income of $21.90 Million, suggesting accrual-heavy earnings not yet converted to cash. See Mersana Therapeutics Inc (MRSN) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-1.13x
Operating CF / Net Income
Operating Cash Flow
$-24.69 Million
USD
Net Income
$21.90 Million
USD
Data as of
Mar 2019
Most recent filing
Mersana Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Mersana Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Mersana Therapeutics Inc. For the full cash flow conversion analysis, see MRSN operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.